Comparative study of Unna's Boot and betamethasone cream in the treatment of sulfur mustard-related pruritus

Cutaneous and Ocular Toxicology

Volumn 26, Issue 4, 2007, Pages 303-309

  Shohrati, Majid ^a   Davoudi, Masoud ^a   Almasi, Mahmoud ^a   Sadr, Bardia ^a   Peyman, Mohammadreza ^b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Young Researchers Club   (Iran)

Author keywords

Betamethasone; Pruritus; Sulfur mustard; Unna's Boot

Indexed keywords

ANTIPRURITIC AGENT; BETAMETHASONE; MUSTARD GAS; PLACEBO; UNCLASSIFIED DRUG; UNNA BOOT CREAM;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, TOPICAL; ADULT; BETAMETHASONE; DRUG COMBINATIONS; GELATIN; GLYCEROL; HUMANS; MALE; MIDDLE AGED; MUSTARD GAS; PRURITUS; ZINC COMPOUNDS;

EID: 36749005600     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.1080/15569520701588723     Document Type: Article

References (38)

1. Papirmeister B, Feister AJ, Robinson SI, Ford RD. Medical Defense Against Mustard Gas: Toxic Mechanisms and Pharmacological Implications. Boston: CRC Press, 1991:2-3, 14-32, 49, 61, 69, 79-86, 100-115, 174-199.
2. Petrali JP, Oglesby SB, Mills KR. Ultrastructural correlates of sulfur mustard toxicity. J Toxicol-Cut Ocular Toxicol 1990; 9:193-214.
3. Petrali JP, Oglesby SB, Hamilton TA, Mills KR. Ultrastructural pathology and immunohistochemistry of mustard gas lesion. Proceedings of the 1993 Medical Defence Bioscience review. USAMRICD, APG, MD, 15-20. AD A275667.
4. Vogt RF, Dannenberg AM, Schofield BH, Hynes NA, Papirmeister B. Pathogenesis of skin lesions caused by sulfur mustard. Fund Appl Toxicol 1984; 4:S71-S83.
5. Mitcheltree LW, Mershon MM, Wall HG, Pulliam JD, Manthei JH. Microblister formation in vesicant-exposed pig skin. J Toxicol-Cut Ocular Toxicol 1989; 8:309-319.
6. Kehe K, Szinicz L. Medical aspects of sulphur mustard poisoning Toxicology. 2005 Oct 30; 214(3):198-209.
7. Vogt RF, Dannenberg AM, Schofield BH, Hynes NA, Papirmeister B. Pathogenesis of skin lesions caused by sulphur mustard. Fundam Appl Toxicol 1984; 4:S71-S83.
8. Monteiro-Riviere NA, Inman, AO. Histochemical localisation of three basement membrane epitopes with sulphur mustard induced toxicity in porcine skin. Toxicologist 1993; 13:58.
9. Elasyed NM, Omaye ST, Klain GJ, Korte DW. Free radical mediated lung response to the monofunctional sulfur mustard butyl 2-chloroethyl sulfide after subcutaneous injection. Toxicology 1992; 72:153-165.
10. Willems JL. Clinical management of mustard gas casualties. Ann Med Mil Belg 1989; 3:S1-S61.
11. Sohrabpour H. Clinical manifestations of chemical agents on iranian combatants during the Iran-Iraq conflict. In: Heyndrickx A, ed. Proceedings of the First World Congress on New Compounds in Biological and Chemical Warfare. Ghent, Belgium: Rijksuniversiteit; 1984:291-297.
12. Momeni AZ, Enshaeih S, Meghadi M, Amindjavaheri M. Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas. Arch Dermatol 1992; 128:775-780.
13. Mellor SG, Rice P, Cooper GJ. Vesicant agents. Br J Plast Surg 1991; 44:434-437.
14. Malgorzata K, Zbigniew Z. Pruritus in advanced internal disease pathogenesis & treatment. Netherlands J of Med 2001; 58:27-40.
15. Herman SM, Vender RB. Antihistamines in the treatment of atopic dermatitis. J Cutan Med Surg 2003; Nov-Dec; 7(6):467-473.
16. Monroe EW, Daly AF, Shalhoub RF. Appraisal of the validity of histamine induced wheal and flare to predict the clinical efficacy of histamines. J Allergy Clin Immunol 1998 Aug; 102(2):333-334.
17. Sweetman SC. Martindale: The Complete Drug Reference. 34th Edition. Pharmaceutical Press; 2004:1063.
18. Hercogová J. Topical anti-itch therapy. Dermatologic Therapy 2005; 18(4):341-345.
19. Misery L. Commentary 3. Experimental Dermatology 2005; 14(3):235-238.
20. Lipozencic J, Ljobojevic S. Insect stings. Acta Dermatovenerol Croat 2006; 14(3):208.
21. Millikan LE. Alternative therapy in pruritus. Dermatologic Therapy 2003; 16(2):175-179.
22. Naimer SA, Cohen AD, Mumcuoglu KY, Vardy DA. Household papular urticaria. Isr Med Assoc J 2002; 4(11 Suppl):911-913.
23. Sanford S, Gore D. Unna's Boot dressing facilitates outpatient skin grafting of hands. J Burn care Rehabil 1996; 17(4):323-326.
24. Bergan JJ, Sparks SR. Non-elastic compression; an alternative in management of chronic venous insufficiency. J Wound Ostomy Continence Nurs 2000; 27(2):83-89.
25. Balaskas EV, Bamihas GI, Karamouzis M, Voyitasis G, Tourkantonis A. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-Pruritus patients. J Nephron 1998; 78:395-402.
26. Yang T, Breen TW, Archer D, Fick G. Comparison of 0.25 mg and 0.1 mg intrathecal morphine for analgesia after Cesarean section. Can J Anaesth 1999; 46:856-860.
27. Rice P. Sulphur mustard injuries of the skin, Pathophysiology and management. Toxicol Rev 2003; 22:111-118.
28. Klein PA, Clark RAF. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 1999; 135:1522-1525.
29. Nordness M, Zacharisen MC. A case report: high dose Cetirizine. Cutis 2003; 71:296.
30. Kawashima M, Tango T, Noguchi T, Inagi M, Nakagawa H, Harada S. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study. Br J Dermatol 2003; 148:1212-1221.
31. Sweetman SC. Martindale: The Complete Drug Reference. 34th Edition. Pharmaceutical Press; 2004:1116, 954.
32. Hile DC, Coon TP, Skinner CG, Hile LM, Levy P, Patel MM, Miller MA. Treatment of imported fire ant stings with mitigator sting and bite treatment - a randomized control study. Wilderness Environ Med 2006; 17(1):21-25.
33. Sujata S, Kumar DJ, Asok G. Case report: alagille syndrome with prominent skin manifestations. IJDVL 2005; 71(2):119-121.
34. Millikan LE. Pruritus: unapproved treatments or indications. Clinics in Dermatology 2000; 18(2):149-152.
35. Sadovsky R. Poison ivy, oak and sumac contact dermatitis. American Family Physician, June 1, 2000.
36. Dunlop K, Freeman S. Caterpillar dermatitis. Australas J Dermatol 1997; 38(4):193-195.
37. Godfrey HR, Godfrey NJ, Godfrey JC, Riley D. A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine. Altern Ther Health Med 2001; 7(3):49-56.
38. Heyman WR. Threats of biological and chemical warfare on civilian populations. J Am Acad Dermatol 2004; 51(3):452-453.